Simon Nitschky Schmidt, PhD

Good, moderate, and poor functioning of adult patients with schizophrenia treated with aripiprazole once-monthly or paliperidone palmitate once-monthly in the Qualify study

Introduction QUALIFY was a 28-week, randomized, open-label, rater-blinded, head-to-head study (NCT01795547) evaluating effectiveness of aripiprazole once-monthly (AOM 400) vs paliperidone...

Simon Nitschky Schmidt , PhD;

Lizbeth Arias , MD;

Ross Baker , PhD, MBA;

Pedro Such , MD;

Jessica Madera , MD;

10/08/2020

Effects of Aripiprazole Once-Monthly and Paliperidone Palmitate Once Monthly in Patients With Schizophrenia and Concomitant Substance Use: A Post-hoc Analysis of QUALIFY, a Head-to-Head Study

Background: Post-hoc analyses of the QUALIFY study (1), comparing effects of aripiprazole once-monthly (AOM 400) and paliperidone palmitate once-monthly (PP1M) treatment in patients with ...

Ross Baker , PhD, MBA;

Pedro Such , MD;

Jessica Madera , MD;

Simon Nitschky Schmidt , PhD;

Anna-Greta Nylander , PhD;

11/22/2019